Andreatos, Nikolaos
McGarrah, Patrick W.
Sonbol, Mohamad Bassam
Starr, Jason S.
Capdevila, Jaume
Sorbye, Halfdan
Halfdanarson, Thorvardur R. http://orcid.org/0000-0001-8460-1257
Article History
Accepted: 21 June 2023
First Online: 22 August 2023
Declarations
:
: Nikolaos Andreatos and Patrick W. McGarrah declare no conflict of interest. Mohamad Bassam Sonbol is the recipient of research grants from Eli Lilly and Taiho (paid to institution) and has received compensation for consulting services from Novartis. Jason S. Starr has received compensation for consulting services from TerSera, Advanced Accelerator Applications, Pfizer, Taiho, Ipsen, Natera, Tempus, Cancer Expert Now, and Helsinn Therapeutics and support for attending meetings/travel from Camurus. Jaume Capdevila is the recipient of grants/contracts from Novartis, Pfizer, AstraZeneca, Advanced Accelerator Applications, Eisai, Amgen, and Bayer, has received compensation for consulting services from Novartis, Pfizer, Ipsen, Exelixis, Bayer, Eisai, Advanced Accelerator Applications, Amgen, Sanofi, Lilly, Hutchinson Pharma, ITM, Advanz, Merck Serono, Esteve, and Roche and payment or honoraria for lectures/presentations/speakers’ bureaus/manuscript writing/educational events from Novartis, Pfizer, Ipsen, Exelixis, Bayer, Eisai, Advanced Accelerator Applications, Amgen, Sanofi, Lilly, Hutchinson Pharma, ITM, Advanz, Merck Serono, Esteve, and Roche. Halfdan Sorbye has received compensation for consulting services from Hutchinson and Advanced Accelerator Applications, payment or honoraria for lectures/presentations/speakers’ bureaus/manuscript writing/educational events from Novartis, Ipsen, Bayer, SAM Nordic, and Pierre Fabre, and has participated on Data Safety Monitoring/Advisory Boards for ITM and Bayer. Thorvardur R. Halfdanarson has received compensation for consulting services from TerSera and Terumo, payment or honoraria for lectures/presentations/speakers’ bureaus/manuscript writing/educational events from OncLive, and has participated on Data Safety Monitoring/Advisory Boards for ITM and Camurus. He currently serves as the Vice President of the North American Neuroendocrine Tumor Society without financial compensation. He has performed consulting services without personal compensation (all fees paid to Mayo Clinic) for Ipsen, Advanced Accelerator Applications, Crinetics, Camurus, TerSera, and Viewpoint Molecular Imaging. Funding for research has been provided to Mayo Clinic on his behalf from Advanced Accelerator Applications, Crinetics, Camurus, and Thermo Fisher Scientific.
: Not applicable as the study constitutes a literature review.